John R. Warren
@Farallon Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$20.437BTotal holdings153
Assets growth rate-3.56%Assets growth rate (2-Q avg)-3.73%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Farallon Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 153 positions.
Assets under management
The assets under management (AUM) of Farallon Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 20.437B in assets, with a quarterly growth rate of -3.56% and a 2-quarter average growth rate of -3.73%. The portfolio is managed by John R. Warren, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MASIMasimo Corp
| 0.83% | $167.804M 1.259M shares@ $133.34 avg price | Increased 12.42% |
THCTenet Healthcare Corp
| 0.57% | $115.084M 692,442 shares@ $166.2 avg price | Increased 0.73% |
LBPHLongboard Pharmaceuticals In
| 0.52% | $105.018M 3.151M shares@ $33.34 avg price | Increased 7.16% |
ICLRIcon Plc
| 0.32% | $63.438M 220,800 shares@ $287.31 avg price | Increased 23.91% |
CRNXCrinetics Pharmaceuticals In
| 0.3% | $59.378M 1.162M shares@ $51.1 avg price | Increased 133.81% |
CNTACentessa Pharmaceuticals Plc
| 0.23% | $45.001M 2.814M shares@ $16.0 avg price | Increased 41% |
LQDALiquidia Corporation
| 0.17% | $32.91M 3.291M shares@ $10.0 avg price | Increased 60.15% |
GDSGds Hldgs Ltd
| 0.16% | $31.235M 1.531M shares@ $20.4 avg price | Increased 24.88% |
ENTAEnanta Pharmaceuticals Inc
| 0.11% | $21.842M 2.108M shares@ $10.36 avg price | Increased 0.64% |
TECXTectonic Therapeutic Inc
| 0.08% | $15.768M 520,397 shares@ $30.3 avg price | Increased 20.74% |